DiaSorin Italia S.p.A.
IT-MF-000029422 · Italy · Saluggia
DiaSorin Italia S.p.A. is registered in the European database on medical devices as a manufacturer, with 151 devices declared. It is also registered as a device establishment with the U.S. FDA.
What this manufacturer declares
Devices declared under this manufacturer
- LIAISON® Borrelia IgG
- LIAISON® Cardiolipin IgG
- LIAISON® Cardiolipin IgM
- LIAISON® Control Anti-HAV
- LIAISON® Control Anti-TPO
- LIAISON® Control Bordetella pertussis Toxin IgA
- LIAISON® Control PSA II Gen
- LIAISON® Control Rubella IgM
- LIAISON® Measles IgM
- LIAISON® Mumps IgM
- LIAISON® QuantiFERON®-TB Gold Plus II
- LIAISON® Rubella IgG II
Showing 12 of 151 declared devices.
Catalogue references include 310171, 310370, 310380, 310731, 311321, 314501.
European nomenclature codes declared: W0105080804, W0105080801, W0102152005, W0102152008, W0102152002, W0105080802.
United States market access
| FDA establishment register | Registered with FDA |
|---|---|
| Matched entry | DiaSorin Italia S.p.A. (IT) · FDA 9610240 |
| Devices in EUDAMED | 151 |
| Country of registration | Italy |
Device-level evidence
| Devices with a numeric GTIN | 151 |
|---|---|
| Found in the U.S. device database | 18 |
| Share | 11.9 % |
Canadian market access
| Health Canada licence listing | Not found in the Canadian register |
|---|
⚠️ Canada lists no Class I devices at all — what that excludes.
North American profile: United States only. DiaSorin Italia S.p.A. is registered in the United States but was not found in the Canadian register.